Correlation Between Mereo BioPharma and Immunome
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Immunome, you can compare the effects of market volatilities on Mereo BioPharma and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Immunome.
Diversification Opportunities for Mereo BioPharma and Immunome
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mereo and Immunome is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Immunome go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Immunome
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Immunome. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 1.59 times less risky than Immunome. The stock trades about -0.16 of its potential returns per unit of risk. The Immunome is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 1,147 in Immunome on September 1, 2024 and sell it today you would earn a total of 208.00 from holding Immunome or generate 18.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Immunome
Performance |
| Timeline |
| Mereo BioPharma Group |
| Immunome |
Mereo BioPharma and Immunome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Immunome
The main advantage of trading using opposite Mereo BioPharma and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |